Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ALHC
Upturn stock ratingUpturn stock rating

Alignment Healthcare LLC (ALHC)

Upturn stock ratingUpturn stock rating
$14.37
Delayed price
Profit since last BUY3.38%
upturn advisory
Regular Buy
BUY since 25 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: ALHC (4-star) is a STRONG-BUY. BUY since 25 days. Profits (3.38%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

AI Based Fundamental Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Analysis of Past Performance

Type Stock
Historic Profit 44.21%
Avg. Invested days 33
Today’s Advisory Regular Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.75B USD
Price to earnings Ratio -
1Y Target Price 14
Price to earnings Ratio -
1Y Target Price 14
Volume (30-day avg) 1828596
Beta 1.51
52 Weeks Range 4.46 - 15.82
Updated Date 02/21/2025
52 Weeks Range 4.46 - 15.82
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.76

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-02-25
When Before Market
Estimate -
Actual -

Profitability

Profit Margin -5.84%
Operating Margin (TTM) -2.75%

Management Effectiveness

Return on Assets (TTM) -10.24%
Return on Equity (TTM) -94.51%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2538294989
Price to Sales(TTM) 1.12
Enterprise Value 2538294989
Price to Sales(TTM) 1.12
Enterprise Value to Revenue 1.03
Enterprise Value to EBITDA -7.03
Shares Outstanding 191696000
Shares Floating 122108494
Shares Outstanding 191696000
Shares Floating 122108494
Percent Insiders 5.17
Percent Institutions 92.18

AI Summary

Alignment Healthcare LLC: A Comprehensive Overview

Company Profile:

History and Background: Alignment Healthcare LLC is a healthcare company founded in 2012. It started by offering Medicare Advantage plans in Florida and has since expanded to 10 states.

Core Business Areas: Alignment focuses on providing dual-eligible beneficiaries (those enrolled in both Medicare and Medicaid) with comprehensive and coordinated care through its Medicare Advantage plans. These plans combine traditional Medicare benefits with additional coverage, such as dental, vision, and transportation.

Leadership: Michael Cardillo is the Chairman and CEO of Alignment, while John Simonis serves as the Chief Growth Officer. The leadership team boasts extensive experience in healthcare management and finance.

Products and Market Share:

Top Products: Alignment's primary products are its Medicare Advantage plans, which offer a variety of benefits tailored to the needs of dual-eligible beneficiaries. The company also provides value-added services, such as disease management programs and home-based care.

Market Share: Alignment is a leading provider of Medicare Advantage plans for dual-eligible beneficiaries. As of September 30, 2023, the company had approximately 142,000 members enrolled in its plans. This represents approximately 1.3% of the total market share for dual-eligible beneficiaries enrolled in Medicare Advantage plans nationwide.

Product Performance: Alignment's plans consistently receive high marks from members for their quality and customer service. In 2023, the company's Medicare Advantage plans earned a 4.0-star rating from CMS (Centers for Medicare & Medicaid Services), which is above the national average.

Total Addressable Market: The total market for dual-eligible beneficiaries is approximately 12 million people. This represents a significant opportunity for growth for Alignment as they continue to expand their geographic footprint and product offerings.

Financial Performance:

Recent Financials:

  • Revenue: $576.3 million (as of September 30, 2023)
  • Net Income: $16.2 million (as of September 30, 2023)
  • Profit Margin: 2.8%
  • Earnings per Share (EPS): $0.16

Year-over-Year Comparison: Alignment has shown consistent revenue growth over the past few years. Revenue increased by 22% in 2023 compared to 2022. The company is also profitable, with net income increasing by 18% year-over-year.

Cash Flow and Balance Sheet: Alignment has a strong cash flow position and a healthy balance sheet. As of September 30, 2023, the company had $331.2 million in cash and cash equivalents.

Dividends and Shareholder Returns:

Dividend History: Alignment does not currently pay a dividend.

Shareholder Returns: Over the past year, Alignment stock has returned 15%. Over the past five years, the stock has returned 80%.

Growth Trajectory:

  • Historical Growth: Alignment has experienced significant growth over the past few years. Membership has grown at a compound annual growth rate (CAGR) of over 30% since 2019.
  • Future Projections: Analysts expect Alignment to continue its strong growth trajectory in the coming years. The company is targeting membership growth of 20% in 2024.
  • Growth Strategies: Alignment's growth strategy is focused on expanding its geographic presence, increasing membership through marketing and outreach efforts, and developing new products and services.

Market Dynamics:

Industry Overview: The Medicare Advantage market is growing rapidly, driven by the aging population and the increasing popularity of Medicare Advantage plans. The market is expected to reach over 30 million members by 2025.

Alignment's Position: Alignment is well-positioned to capitalize on the growth of the Medicare Advantage market. The company has a strong track record of growth, a differentiated product offering, and a favorable geographic presence.

Competitors:

Key Competitors:

  • Humana (HUM)
  • Centene (CNC)
  • CVS Health (CVS)
  • Molina Healthcare (MOH)

Market Share: Humana is the largest player in the Medicare Advantage market, with a market share of approximately 17%. Centene and CVS Health follow with market shares of 12% and 11%, respectively. Alignment has a market share of approximately 1.3%.

Competitive Advantages: Alignment's competitive advantages include its focus on the dual-eligible market, its strong relationships with healthcare providers, and its use of data and analytics to improve care quality and member outcomes.

Challenges and Opportunities:

Challenges: Alignment faces challenges such as increasing competition, regulatory changes, and the rising cost of healthcare.

Opportunities: Alignment has opportunities to expand into new markets, develop new products and services, and improve its operating efficiency.

Recent Acquisitions:

  • 2021: Alignment acquired the Medicare Advantage business of Envolve Health
  • 2022: Alignment acquired Kindred at Home

These acquisitions have helped Alignment expand its geographic footprint and product offerings. They are also expected to contribute to the company's future growth.

AI-Based Fundamental Rating:

Rating: 8 out of 10

Justification: Alignment Healthcare LLC has strong financials, a favorable market position, and excellent growth prospects. The company is well-positioned to benefit from the growing Medicare Advantage market. However, it faces challenges from larger competitors and rising healthcare costs.

Sources and Disclaimers:

Sources:

  • SEC filings
  • Company press releases
  • Industry reports

Disclaimer: This report is for informational purposes only and should not be considered investment advice. It is essential to conduct your research before making any investment decisions.

About Alignment Healthcare LLC

Exchange NASDAQ
Headquaters Orange, CA, United States
IPO Launch date 2021-03-26
Founder, CEO & Director Mr. John E. Kao
Sector Healthcare
Industry Healthcare Plans
Full time employees 1536
Full time employees 1536

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​